Sutro Biopharma (STRO) Amortizatization of Intangibles (2017 - 2025)

Sutro Biopharma (STRO) has 9 years of Amortizatization of Intangibles data on file, last reported at $531000.0 in Q4 2025.

• For the quarter ending Q4 2025, Amortizatization of Intangibles fell 65.5% year-over-year to $531000.0; the trailing twelve-month figure through Dec 2025 stood at $3.4 million (down 64.66% YoY), and the FY2025 full-year result was $3.4 million, down 64.66% from the prior year.
• Amortizatization of Intangibles eased to $531000.0 in Q4 2025, from $755000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.1 million in Q4 2023 to a low of -$799000.0 in Q4 2021.
• A 5-year average of $990600.0 and a median of $1.1 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles slumped 1309.76% in 2021 and soared 2224.27% in 2023, its largest moves.
• Tracing STRO's Amortizatization of Intangibles over 5 years: stood at -$799000.0 in 2021, then surged by 246.93% to $1.2 million in 2022, then surged by 160.05% to $3.1 million in 2023, then sank by 49.59% to $1.5 million in 2024, then slumped by 65.5% to $531000.0 in 2025.
• Business Quant data shows STRO's Amortizatization of Intangibles at $531000.0 in Q4 2025, $755000.0 in Q3 2025, and $1.0 million in Q2 2025.